Company profile RYTM
There is not enough data for Rhythm Pharmaceuticals near me to provide analysis
There is not enough data for Rhythm Pharmaceuticals near me to provide correlation calculation
There is not enough data for Rhythm Pharmaceuticals near me to provide analysis
There is not enough data for IMCIVREE therapy to provide analysis
There is not enough data for IMCIVREE therapy to provide correlation calculation
There is not enough data for IMCIVREE therapy to provide analysis
After 38 days of this quarter the interest is at 24.0. Based on that we can calculate that during remaining 53 days it will total up to 57.0. Rhythm Pharmaceuticals stock expected interest is significantly higher compared to same quarter last year (+216.7%) but lower than previous quarter (-69.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 38 | 75 97.4% QoQ | 22 -70.7% QoQ | 154 600.0% QoQ |
| 2020 | 193 407.9% YoY 25.3% QoQ | 135 80.0% YoY -30.1% QoQ | 70 218.2% YoY -48.1% QoQ | 223 44.8% YoY 218.6% QoQ |
| 2021 | 150 -22.3% YoY -32.7% QoQ | 55 -59.3% YoY -63.3% QoQ | 57 -18.6% YoY 3.6% QoQ | 95 -57.4% YoY 66.7% QoQ |
| 2022 | 153 2.0% YoY 61.1% QoQ | 85 54.5% YoY -44.4% QoQ | 226 296.5% YoY 165.9% QoQ | 48 -49.5% YoY -78.8% QoQ |
| 2023 | 18 -88.2% YoY -62.5% QoQ | 124 45.9% YoY 588.9% QoQ | 112 -50.4% YoY -9.7% QoQ | 186 287.5% YoY 66.1% QoQ |
| 2024 | 24 33.3% YoY -87.1% QoQ | - | - | - |
The average 5 years interest of Rhythm Pharmaceuticals stock was 8.63 per week. The last year interest of Rhythm Pharmaceuticals stock compared to the last 5 years has changed by 3.36%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 42.72%.
There is not enough data for melanocortin-4 receptor deficiency obesity to provide analysis
There is not enough data for melanocortin-4 receptor deficiency obesity to provide correlation calculation
There is not enough data for melanocortin-4 receptor deficiency obesity to provide analysis
After 38 days of this quarter the interest is at 122.0. Based on that we can calculate that during remaining 53 days it will total up to 292.0. Bardet-Biedl syndrome expected interest is significantly higher compared to same quarter last year (+78.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 172 | 133 -22.7% QoQ | 256 92.5% QoQ | 93 -63.7% QoQ |
| 2020 | 167 -2.9% YoY 79.6% QoQ | 207 55.6% YoY 24.0% QoQ | 114 -55.5% YoY -44.9% QoQ | 127 36.6% YoY 11.4% QoQ |
| 2021 | 277 65.9% YoY 118.1% QoQ | 183 -11.6% YoY -33.9% QoQ | 165 44.7% YoY -9.8% QoQ | 238 87.4% YoY 44.2% QoQ |
| 2022 | 242 -12.6% YoY 1.7% QoQ | 307 67.8% YoY 26.9% QoQ | 317 92.1% YoY 3.3% QoQ | 307 29.0% YoY -3.2% QoQ |
| 2023 | 164 -32.2% YoY -46.6% QoQ | 414 34.9% YoY 152.4% QoQ | 145 -54.3% YoY -65.0% QoQ | 382 24.4% YoY 163.4% QoQ |
| 2024 | 122 -25.6% YoY -68.1% QoQ | - | - | - |
The average 5 years interest of Bardet-Biedl syndrome was 17.43 per week. The last year interest of Bardet-Biedl syndrome compared to the last 5 years has changed by 25.53%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 46.06%.
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. Alström syndrome expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 0 -100.0% QoQ | 99 inf% QoQ | 57 -42.4% QoQ |
| 2020 | 132 41.9% YoY 131.6% QoQ | 42 inf% YoY -68.2% QoQ | 140 41.4% YoY 233.3% QoQ | 62 8.8% YoY -55.7% QoQ |
| 2021 | 128 -3.0% YoY 106.5% QoQ | 34 -19.0% YoY -73.4% QoQ | 40 -71.4% YoY 17.6% QoQ | 119 91.9% YoY 197.5% QoQ |
| 2022 | 68 -46.9% YoY -42.9% QoQ | 142 317.6% YoY 108.8% QoQ | 171 327.5% YoY 20.4% QoQ | 50 -58.0% YoY -70.8% QoQ |
| 2023 | 104 52.9% YoY 108.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 118 -31.0% YoY inf% QoQ | 71 42.0% YoY -39.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Alström syndrome was 6.42 per week. The last year interest of Alström syndrome compared to the last 5 years has changed by -35.67%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -23.52%.
There is not enough data for MC4R disorders to provide analysis
There is not enough data for MC4R disorders to provide correlation calculation
There is not enough data for MC4R disorders to provide analysis
There is not enough data for setmelanotide clinical trials to provide analysis
There is not enough data for setmelanotide clinical trials to provide correlation calculation
There is not enough data for setmelanotide clinical trials to provide analysis
There is not enough data for rare genetic diseases of obesity to provide analysis
There is not enough data for rare genetic diseases of obesity to provide correlation calculation
There is not enough data for rare genetic diseases of obesity to provide analysis